期刊
CURRENT OPINION IN PHARMACOLOGY
卷 67, 期 -, 页码 -出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.coph.2022.102304
关键词
-
Fibroblast-like synoviocytes (FLS) play an important role in rheumatoid arthritis (RA), but in RA, fibroblasts become a key driver of synovial inflammation and joint damage. There has been recent interest in targeting FLS for RA treatment and the effects of FLS-targeted drugs are discussed.
Fibroblast-like synoviocytes (FLS) are mesenchymal-derived cells that play an important role in the physiology of the synovium by producing certain components of the synovial fluid and articular cartilage. In rheumatoid arthritis (RA), however, fibroblasts become a key driver of synovial inflammation and joint damage. Because of this, there has been recent interest in FLS as a therapeutic target in RA to avoid side effects such as systemic immune suppression associated with many existing RA treatments. In this review, we describe how approved treatments for RA affect FLS signaling and function and discuss the effects of investigational FLS-targeted drugs for RA.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据